Penlac vs. Jublia
- Are Penlac and Jublia the Same Thing?
- What Are Possible Side Effects of Penlac?
- What Are Possible Side Effects of Jublia?
- What is Penlac?
- What is Jublia?
- What drugs interact with Penlac?
- What drugs interact with Jublia?
- How Should Penlac Be Taken?
- How Should Jublia Be Taken?
What Drugs Interact With Penlac?
Penlac Nail Lacquer may interact with other topical products. Do not use nail polish, artificial nails, or other cosmetic nail products on the nails treated with Penlac Nail Lacquer.
Other drugs may interact with Penlac. Tell your doctor all prescription or over-the-counter medicines and supplements you use.
What Drugs Interact With Jublia?
The impact of nail polish or other cosmetic nail products on the effectiveness of Jublia is unknown.
Other drugs may interact with Jublia. Tell your doctor all prescription or over-the-counter medicines and supplements you use.
How Should Penlac Be Taken?
Penlac Nail Lacquer Topical Solution, 8%, should be applied once daily (preferably at bedtime or eight hours before washing) to all affected nails and over the entire nail plate with the applicator brush provided. The unattached, infected nail should be removed as frequently as monthly by a health care professional, and trimmed weekly by the patient, along with daily application of the medication. Penlac Nail Lacquer may interact with other topical products. Do not use nail polish, artificial nails, or other cosmetic nail products on the nails treated with Penlac Nail Lacquer. Other drugs may interact with Penlac Nail Lacquer. Tell your doctor all prescription or over-the-counter medicines and supplements you use. During pregnancy, Penlac Nail Lacquer should be used only when prescribed. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
How Should Jublia Be Taken?
Apply a once-daily dose of Jublia to affected toenails for 48 weeks, using the integrated flow-through brush applicator. Jublia may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Jublia should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.